Menlo Therapeutics Inc.
200 Cardinal Way, 2nd Floor
Redwood City, CA 94063
|
| |
| VIA EDGAR | January 22, 2018 |
U.S. Securities and Exchange Commission
Division of Corporate Finance
Office of Healthcare and Insurance
100 F Street, N.E.
Washington, D.C. 20549
|
| |
| Attention: | Chris Edwards / Erin Jaskot – Legal |
| | Christine Torney / Jim Rosenberg – Accounting |
|
| |
| Re: | Menlo Therapeutics Inc. |
| | Withdrawal of Request for Acceleration of Effectiveness |
| | Registration Statement on Form S-1 (File No. 333-222324) |
Ladies and Gentlemen:
Menlo Therapeutics Inc. hereby withdraws its request for the acceleration of effectiveness of the Registration Statement on Form S-1 (File No. 333-222324) as set forth in its letter dated January 22, 2018.
|
| |
| Very truly yours, |
| | |
| Menlo Therapeutics Inc. |
| | |
| By: | /s/ Steven Basta |
| Name: | Steven Basta |
| Title: | President and Chief Executive Officer |
